Per Marits

Publications
Public outreach and news

Articles

Article: HLA. 2024;103(3):e15430
Identification of the novel HLA-A02:01:01:251 allele in a candidate bone marrow donor by next-generation sequencing
Gaballa A; Schaffer M; Marits P; Eich T
Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2024;44(2):50
Evaluation of Genetic or Cellular Impairments in Type I IFN Immunity in a Cohort of Young Adults with Critical COVID-19
Covill LE; Sendel A; Campbell TM; Piiroinen I; Enoksson SL; Borgstrom EW; Hansen S; Ma K; Marits P; Norlin AC; Smith CIE; Kahlin J; Eriksson LI; Bergman P; Bryceson YT
Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1257581
Case report: IKZF1-related early-onset CID is expected to be missed in TREC-based SCID screening but can be identified by determination of KREC levels
Ang C; Zetterstrom RH; Ramme K; Axelsen E; Marits P; Sundin M
Article: JOURNAL OF EXPERIMENTAL MEDICINE. 2022;219(7):e20220202
Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency
Campbell TM; Liu Z; Zhang Q; Moncada-Velez M; Covill LE; Zhang P; Darazam IA; Bastard P; Bizien L; Bucciol G; Enoksson SL; Jouanguy E; Karabela SN; Khan T; Kendir-Demirkol Y; Augusto Arias A; Mansouri D; Marits P; Marr N; Migeotte I; Moens L; Ozcelik T; Pellier I; Sendel A; Senoglu S; Shahrooei M; Smith CIE; Vandernoot I; Willekens K; Yasar KK; Bergman P; Abel L; Cobat A; Casanova J-L; Meyts I; Bryceson YT
Article: JOURNAL OF IMMUNOLOGICAL METHODS. 2021;499:113159
A flow cytometry-based proliferation assay for clinical evaluation of T-cell memory against SARS-CoV-2
Enoksson SL; Bergman P; Klingstrom J; Bostrom F; Rodrigues RDS; Winerdal ME; Marits P
Article: INTERNATIONAL JOURNAL OF NEONATAL SCREENING. 2021;7(3):59
First Year of TREC-Based National SCID Screening in Sweden
Gongrich C; Ekwall O; Sundin M; Brodszki N; Fasth A; Marits P; Dysting S; Jonsson S; Barbaro M; Wedell A; von Dobeln U; Zetterstrom RH
Article: GENOME MEDICINE. 2021;13(1):40
Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients
Stranneheim H; Lagerstedt-Robinson K; Magnusson M; Kvarnung M; Nilsson D; Lesko N; Engvall M; Anderlid B-M; Arnell H; Johansson CB; Barbaro M; Bjorck E; Bruhn H; Eisfeldt J; Freyer C; Grigelioniene G; Gustavsson P; Hammarsjo A; Hellstrom-Pigg M; Iwarsson E; Jemt A; Laaksonen M; Enoksson SL; Malmgren H; Naess K; Nordenskjold M; Oscarson M; Pettersson M; Rasi C; Rosenbaum A; Sahlin E; Sardh E; Stodberg T; Tesi B; Tham E; Thonberg H; Tohonen V; von Dobeln U; Vassiliou D; Vonlanthen S; Wikstrom A-C; Wincent J; Winqvist O; Wredenberg A; Ygberg S; Zetterstrom RH; Marits P; Soller MJ; Nordgren A; Wirta V; Lindstrand A; Wedell A
Article: TRANSFUSION. 2021;61(2):464-473
Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study
Zhao J; Gabriel E; Norda R; Hoglund P; Baden L; Diedrich BA; Marits P; Enoksson SL; Gansner JM; Kaufman R; Dickman PW; Edgren G
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2020;91(2):e12830
Tumour-associated B cells in urothelial urinary bladder cancer
Zirakzadeh AA; Sherif A; Rosenblatt R; Bergman EA; Winerdal M; Yang D; Cederwall J; Jakobsson V; Hyllienmark M; Winqvist O; Marits P
Article: FRONTIERS IN IMMUNOLOGY. 2020;11:1365
Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier
Kharlamova N; Hermanrud C; Dunn N; Ryner M; Hambardzumyan K; Pomiano NV; Marits P; Gjertsson I; Saevarsdottir S; Pullerits R; Fogdell-Hahn A
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(5):362-366
Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population
Hambardzumyan K; Hermanrud C; Marits P; Vivar N; Ernestam S; Wallman JK; van Vollenhoven RF; Fogdell-Hahn A; Saevarsdottir S
Article: JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2019;41(2):155-157
"Immune" Thrombocytopenia as Key Feature of a Novel ADA2 Deficiency Variant: Implication on Differential Diagnostics of ITP in Children
Sundin M; Marits P; Nierkens S; Kolios AGA; Nilsson J
Article: CLINICAL IMMUNOLOGY. 2019;200:16-18
Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C
Sundin M; Marits P; Ramme K; Kolios AGA; Nilsson J
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2018;88(6):e12722
CCR2 upregulated on peripheral T cells in osteoarthritis but not in bone marrow
Arkestal K; Mints M; Enocson A; Linton L; Marits P; Glise H; Andersson J; Winqvist O
Article: BMC PEDIATRICS. 2018;18(1):285
Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report
Lundin KE; Wang Q; Hamasy A; Marits P; Uzunel M; Wirta V; Wikstrom A-C; Fasth A; Ekwall O; Smith CIE
Article: CLINICAL EPIGENETICS. 2018;10(1):102
Increased CD4⁺ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients
Bergman EA; Hartana CA; Johansson M; Linton LB; Berglund S; Hyllienmark M; Lundgren C; Holmstrom B; Palmqvist K; Hansson J; Alamdari F; Huge Y; Aljabery F; Riklund K; Winerdal ME; Krantz D; Zirakzadeh AA; Marits P; Sjoholm LK; Sherif A; Winqvist O
Article: CANCER IMMUNOLOGY RESEARCH. 2018;6(5):528-538
Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness
Winerdal ME; Krantz D; Hartana CA; Zirakzadeh AA; Linton L; Bergman EA; Rosenblatt R; Vasko J; Alamdari F; Hansson J; Holmstrom B; Johansson M; Winerdal M; Marits P; Sherif A; Winqvist O
Article: WORLD JOURNAL OF UROLOGY. 2017;35(6):921-927
Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report
Rosenblatt R; Johansson M; Alamdari F; Sidiki A; Holmstrom B; Hansson J; Vasko J; Marits P; Gabrielsson S; Riklund K; Winqvist O; Sherif A
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2017;18(3):E575-575
Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment
Rolandsdotter H; Marits P; Sundin U; Wikstrom A-C; Fagerberg UL; Finkel Y; Eberhardson M
Article: CLINICAL IMMUNOLOGY. 2017;176:63-70
Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer
Zirakzadeh AA; Kinn J; Krantz D; Rosenblatt R; Winerdal ME; Hu J; Hartana CA; Lundgren C; Bergman EA; Johansson M; Holmstrom B; Hansson J; Sidikii A; Vasko J; Marits P; Sherif A; Winqvist O
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2015;49(6):453-462
Pilot study of adoptive immunotherapy with sentinel node-derived T cells in muscle-invasive urinary bladder cancer
Sherif A; Hasan MN; Radecka E; Rodriguez AL; Shabo S; Karlsson M; Schumacher MC; Marits P; Winqvist O
Article: JOURNAL OF CROHNS & COLITIS. 2014;8(8):881-889
Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment
Marits P; Landucci L; Sundin U; Davidsdottir L; Nilsson J; Befrits R; Wikstrom A-C; Eberhardson M
Article: CLINICAL IMMUNOLOGY. 2014;153(2):332-342
Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay
Marits P; Wikstrom A-C; Popadic D; Winqvist O; Thunberg S
Article: CLINICAL IMMUNOLOGY. 2013;149(1):73-82
Treatment of inflammatory bowel disease by chemokine receptor-targeted leukapheresis
Eberhardson M; Marits P; Jones M; Jones P; Karlen P; Karlsson M; Cotton G; Woznica K; Maltman B; Glise H; Winqvist O
Article: JOURNAL OF IMMUNOLOGY. 2013;190(11):5847-5855
Multiplex B Cell Characterization in Blood, Lymph Nodes, and Tumors from Patients with Malignancies
Zirakzadeh AA; Marits P; Sherif A; Winqvist O
Article: BJU INTERNATIONAL. 2011;108(10):1672-1678
FOXP3 and survival in urinary bladder cancer
Winerdal ME; Marits P; Winerdal M; Hasan M; Rosenblatt R; Tolf A; Selling K; Sherif A; Winqvist O
Article: JOURNAL OF IMMUNOLOGY. 2011;186(1):92-102
Profiling of CD4⁺ T Cells with Epigenetic Immune Lineage Analysis
Janson PCJ; Linton LB; Bergman EA; Marits P; Eberhardson M; Piehl F; Malmstrom V; Winqvist O
Article: ANNALS OF SURGICAL ONCOLOGY. 2010;17(7):1747-1757
Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer
Karlsson M; Marits P; Dahl K; Dagoo T; Enerback S; Thorn M; Winqvist O
Article: EUROPEAN UROLOGY. 2010;58(1):105-111
Feasibility of T-Cell-Based Adoptive Immunotherapy in the First 12 Patients with Advanced Urothelial Urinary Bladder Cancer. Preliminary Data on a New Immunologic Treatment Based on the Sentinel Node Concept
Sherif A; Hasan MN; Marits P; Karlsson M; Winqvist O; Thorn M
Article: JOURNAL OF IMMUNOLOGY. 2008;181(4):2878-2886
CpG methylation of the IFNG gene as a mechanism to induce immunosupression in tumor-infiltrating lymphocytes
Janson PCJ; Marits P; Thorn M; Ohlsson R; Winqvist O
Article: ANNALS OF SURGICAL ONCOLOGY. 2008;15(5):1454-1463
Metinel node - The first lymph node draining a metastasis-contains tumor-reactive lymphocytes
Dahl K; Karlsson M; Marits P; Hoffstedt A; Winqvist O; Thorn M
Article: PLOS ONE. 2008;3(2):e1612
FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans
Janson PCJ; Winerdal ME; Marits P; Thorn M; Ohlsson R; Winqvist O
Article: BRITISH JOURNAL OF CANCER. 2006;94(10):1478-1484
Sentinel node lymphocytes:: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer
Marits P; Karlsson M; Dahl K; Larsson P; Wanders A; Thorn M; Winqvist O
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2006;36(2):305-317
Increased antigen presenting cell-mediated T cell activation in mice and patients without the autoimmune regulator
Ramsey C; Hässler S; Marits P; Kämpe O; Surh CA; Peltonen L; Winqvist O
Article: EUROPEAN UROLOGY. 2006;49(1):59-70
Detection of immune responses against urinary bladder cancer in sentinel lymph nodes
Marits P; Karlsson M; Sherif A; Garske U; Thörn M; Winqvist O
Article: CLINICAL CHEMISTRY. 2005;51(4):768-775
Analysis of T-cell receptor Vβ gene repertoires after immune stimulation and in malignancy by use of padlock probes and microarrays
Banér J; Marits P; Nilsson M; Winqvist O; Landegren U
Show more

All other publications

Letter: PEDIATRIC ALLERGY AND IMMUNOLOGY. 2018;29(1):108-111
Late presenting atypical severe combined immunodeficiency (SCID) associated with a novel missense mutation in DCLRE1C
Sundin M; Uhlin M; Gaballa A; Ramme K; Kolios AGA; Marits P; Nilsson J
Letter: JOURNAL OF IMMUNOLOGY. 2013;191(9):4471-4472
Response to Comment on "Multiplex B Cell Characterization in Blood, Lymph Nodes, and Tumors from Patients with Malignancies"
Marits P; Zirakzadeh AA; Sherif A; Winqvist O
Editorial comment: ONCOIMMUNOLOGY. 2013;2(8):e25237
The many flavors of tumor-associated B cells
Marits P; Zirakzadeh AA; Sherif A; Winqvist O
Editorial comment: CLINICAL IMMUNOLOGY. 2013;147(1):23-26
Predictive immunomonitoring - The COST ENTIRE initiative
Popadic D; Anegon I; Baeten D; Eibel H; Giese T; Marits P; Martinez-Caceres E; Mascart F; Nestle F; Pujol-Borrell R; Savic E; Scheibenbogen C; Seliger B; Thunberg S; Turina M; Villanova F; Winqvist O; Wikstrom A-C

Articles

All other publications

News from KI

Events from KI